Science Translational Medicine
27 November 2019 Vol 11, Issue 520
A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groups
By Lori E. Dodd, Dean Follmann, Michael Proschan, Jing Wang, Denis Malvy, Johan van Griensven, Iza Ciglenecki, Peter W. Horby, Rashid Ansumana, Jia-Fu Jiang, Richard T. Davey, H. Clifford Lane, Aurelie Gouel-Cheron
Science Translational Medicine27 Nov 2019 Restricted Access
Randomized controlled clinical trials are critical for evaluating new experimental therapeutics to treat Ebola virus disease.